According to these findings, TRPV1 expression may have a prognostic value; it has been proven that TRPV1 have a positive correlation with the presence of immune-stimulatory cells, rather than immunosuppressive ones, in several cancer types including oral, ovarian cancer, and melanoma [84]. Here, TRPV1 is linked to ovarian cancer.